Priya Freaney is a Cardiology physician affiliated with Northwestern University. OpenAlex indexes 28 publications with 846 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
675 N Saint Clair St Ste 19-100
Chicago, IL 606115969
Telephone
312-695-4965Provider last certified this registry record 4 Oct 2022.
Clinical trials
- Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cleerly, Inc.Program year20252 payments
- Amgen Inc.Program year20251 payment
- Medtronic, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.1%Statin25.3%Atorvastatin Calcium55%Rosuvastatin Calcium45%Part D≥35 patientsBeta blocker22.2%Metoprolol Succinate58%Carvedilol42%Part D≥30 patients+ 9 more classes in this area
Blood & clotting
8.5%Factor Xa inhibitor5.7%Eliquis100%Part D≥16 patientsP2Y12 inhibitor2.8%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
4.4%SGLT2 inhibitor4.4%Jardiance100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patients at Elevated Risk for Heart Failure Exhibit Reduced Retinal Perfusion
Journal of VitreoRetinal Diseases
2026 - Obstetrical Management of Severe Hypertriglyceridemia in Pregnancy: A Case Report
American Journal of Perinatology Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”